ACW 32.3% 4.1¢ actinogen medical limited

XanaHES and its implications for Actinogen, page-3

  1. 8,366 Posts.
    lightbulb Created with Sketch. 1379
    @krispi

    Thank you for your excellent post.

    I agree with the medical aspects.

    I disagree with the 1 in 250 chance valuation calculation. That would be correct if no more expenditure was required to reach drug approval stage. But there's a lot more expenditure required to reach drug approval stage. The market is taking that into account, although maybe inaccurately.
 
watchlist Created with Sketch. Add ACW (ASX) to my watchlist
(20min delay)
Last
4.1¢
Change
0.010(32.3%)
Mkt cap ! $110.0M
Open High Low Value Volume
3.3¢ 4.2¢ 3.3¢ $775.2K 20.62M

Buyers (Bids)

No. Vol. Price($)
8 1007112 4.0¢
 

Sellers (Offers)

Price($) Vol. No.
4.1¢ 96543 1
View Market Depth
Last trade - 16.10pm 26/06/2024 (20 minute delay) ?
ACW (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.